These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 31552042)

  • 1. Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production.
    Hillen MR; Pandit A; Blokland SLM; Hartgring SAY; Bekker CPJ; van der Heijden EHM; Servaas NH; Rossato M; Kruize AA; van Roon JAG; Radstake TRDJ
    Front Immunol; 2019; 10():2096. PubMed ID: 31552042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators.
    Lopes AP; Bekker CPJ; Hillen MR; Blokland SLM; Hinrichs AC; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
    Front Immunol; 2021; 12():701656. PubMed ID: 34413853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
    Maria NI; Steenwijk EC; IJpma AS; van Helden-Meeuwsen CG; Vogelsang P; Beumer W; Brkic Z; van Daele PL; van Hagen PM; van der Spek PJ; Drexhage HA; Versnel MA
    Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated miRNome of plasmacytoid dendritic cells from patients with Sjögren's syndrome is associated with processes at the centre of their function.
    Hillen MR; Chouri E; Wang M; Blokland SLM; Hartgring SAY; Concepcion AN; Kruize AA; Burgering BMT; Rossato M; van Roon JAG; Radstake TRDJ
    Rheumatology (Oxford); 2019 Dec; 58(12):2305-2314. PubMed ID: 31131409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients.
    Shimizu T; Nakamura H; Takatani A; Umeda M; Horai Y; Kurushima S; Michitsuji T; Nakashima Y; Kawakami A
    Clin Exp Immunol; 2019 Apr; 196(1):39-51. PubMed ID: 30446998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Sjögren's syndrome and the type I interferon system.
    Nordmark G; Eloranta ML; Ronnblom L
    Curr Pharm Biotechnol; 2012 Aug; 13(10):2054-62. PubMed ID: 22208657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome.
    Gottenberg JE; Cagnard N; Lucchesi C; Letourneur F; Mistou S; Lazure T; Jacques S; Ba N; Ittah M; Lepajolec C; Labetoulle M; Ardizzone M; Sibilia J; Fournier C; Chiocchia G; Mariette X
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2770-5. PubMed ID: 16477017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the role of cDC2s in Sjögren's syndrome: transcriptomic profile links altered antigen processes with IFN signature and autoimmunity.
    Lopes AP; Hillen MR; Hinrichs AC; Blokland SL; Bekker CP; Pandit A; Kruize AA; Radstake TR; van Roon JA
    Ann Rheum Dis; 2023 Mar; 82(3):374-383. PubMed ID: 36171070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
    Zhao J; Kubo S; Nakayamada S; Shimajiri S; Zhang X; Yamaoka K; Tanaka Y
    Mod Rheumatol; 2016 Sep; 26(5):716-24. PubMed ID: 26706891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-130a Contributes to Type-2 Classical DC-activation in Sjögren's Syndrome by Targeting Mitogen- and Stress-Activated Protein Kinase-1.
    Lopes AP; van Roon JAG; Blokland SLM; Wang M; Chouri E; Hartgring SAY; van der Wurff-Jacobs KMG; Kruize AA; Burgering BMT; Rossato M; Radstake TRDJ; Hillen MR
    Front Immunol; 2019; 10():1335. PubMed ID: 31281310
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren's syndrome.
    Huijser E; Bodewes ILA; Lourens MS; van Helden-Meeuwsen CG; van den Bosch TPP; Grashof DGB; van de Werken HJG; Lopes AP; van Roon JAG; van Daele PLA; Brkic Z; Dik WA; Versnel MA
    Rheumatology (Oxford); 2022 Aug; 61(8):3491-3496. PubMed ID: 35022662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription profiling of peripheral B cells in antibody-positive primary Sjögren's syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature.
    Imgenberg-Kreuz J; Sandling JK; Björk A; Nordlund J; Kvarnström M; Eloranta ML; Rönnblom L; Wahren-Herlenius M; Syvänen AC; Nordmark G
    Scand J Immunol; 2018 May; 87(5):e12662. PubMed ID: 29655283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome Analysis of CCR9+ T Helper Cells From Primary Sjögren's Syndrome Patients Identifies CCL5 as a Novel Effector Molecule.
    Hinrichs AC; Blokland SLM; Lopes AP; Wichers CGK; Kruize AA; Pandit A; Radstake TRDJ; van Roon JAG
    Front Immunol; 2021; 12():702733. PubMed ID: 34386009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome.
    Li N; Li L; Wu M; Li Y; Yang J; Wu Y; Xu H; Luo D; Gao Y; Fei X; Jiang L
    Front Immunol; 2021; 12():697157. PubMed ID: 34367157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
    Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Wang J; She C; Li Z; Tang N; Xu L; Liu Z; Liu B
    Immunopharmacol Immunotoxicol; 2020 Feb; 42(1):28-36. PubMed ID: 31876196
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren's syndrome.
    Kabeerdoss J; Sandhya P; Kurien BT; Scofield RH; Danda D
    Rheumatol Int; 2022 Mar; 42(3):545-551. PubMed ID: 33861386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjogren's syndrome.
    Vogelsang P; Brun JG; Oijordsbakken G; Skarstein K; Jonsson R; Appel S
    Ann Rheum Dis; 2010 Jun; 69(6):1235-8. PubMed ID: 19914903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-β inhibits inflammatory responses mediators via suppression of iNOS signaling pathway in PBMCs from patients with primary Sjögren's syndrome.
    Benchabane S; Belkhelfa M; Belguendouz H; Zidi S; Boudjelida A; Youinou P; Touil-Boukoffa C
    Inflammopharmacology; 2018 Oct; 26(5):1165-1174. PubMed ID: 29869303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.